Technical Analysis for RGDXQ - Response Genetics

Grade Last Price % Change Price Change
grade B 0.0033 -10.81% -0.0004
RGDXQ closed down 10.81 percent on Tuesday, October 15, 2019, on 10 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical RGDXQ trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%

Older signals for RGDXQ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available from each patient sample. The Company's platforms include analysis of single biomarkers using the polymerase chain reaction method, as well as gene interrogation using microarray methods and fluorescence in situ hybridization (FISH) from paraffin or frozen tissue specimens. The Company is engaged in selling ResponseDX diagnostic testing products. The Company provides pharmacogenomic clinical trial testing services to pharmaceutical companies in the United States, Asia and Europe.
Biotechnology Branches Of Biology Cancer Pharmaceutical Life Sciences Biology Treatment Of Cancer Molecular Biology Biomarkers Genomics Dna Chip Medical Signs Hybridization Pharmacogenomics
Is RGDXQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.0077
52 Week Low 0.0001
Average Volume 233,780
200-Day Moving Average 0.0019
50-Day Moving Average 0.0029
20-Day Moving Average 0.0036
10-Day Moving Average 0.0042
Average True Range 0.0014
ADX 34.38
+DI 30.9091
-DI 23.0303
Chandelier Exit (Long, 3 ATRs ) 0.0035
Chandelier Exit (Short, 3 ATRs ) 0.0064
Upper Bollinger Band 0.0055
Lower Bollinger Band 0.0017
Percent B (%b) 0.42
BandWidth 105.555556
MACD Line 0.0004
MACD Signal Line 0.0004
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0039
Resistance 3 (R3) 0.0040 0.0038 0.0038
Resistance 2 (R2) 0.0038 0.0037 0.0038 0.0038
Resistance 1 (R1) 0.0036 0.0036 0.0035 0.0035 0.0037
Pivot Point 0.0034 0.0034 0.0034 0.0034 0.0034
Support 1 (S1) 0.0032 0.0033 0.0031 0.0031 0.0029
Support 2 (S2) 0.0030 0.0032 0.0030 0.0028
Support 3 (S3) 0.0028 0.0030 0.0028
Support 4 (S4) 0.0027